Discover how Enhanced External Counterpulsation (EECP) evolved over decades from its origins in the 1960s to modern adoption worldwide as a safe, non-invasive heart therapy.
Origin of EECP – Where and Why
Why: In the 1950s–60s, when treatment options for heart blockages were very limited, doctors and engineers began exploring whether blood flow to the heart could be increased without surgery.
At that time, coronary angioplasty (PTCA) and CABG surgery did not exist. (both were developed only after the 1970s).
The goal was to increase blood flow during the heart’s diastolic phase and reduce systolic workload — helping patients recover after a heart attack or get relief from chronic angina.
Who Developed It First
In 1953, Dr. Clauss and colleagues at Harvard, USA researched the concept of intra-aortic balloon pumping, which later inspired the idea of external counterpulsation.
In the 1960s, Dr. Kantrowitz and his team at the State University of New York developed the first External Counterpulsation machine — using inflatable cuffs on the legs and hips, synced with the ECG to push blood during diastole.
In the 1980s–90s, China enhanced this technology with better cuff design, 3-stage inflation, and longer treatment protocols — officially naming it EECP (Enhanced External Counterpulsation).
Timeline of EECP Development
Country-wise Regulations of EECP
Why EECP Still Exists Despite Angioplasty & Bypass
Non-invasive, instant recovery, and effective for patients who cannot undergo surgery (no-option / high-risk cases) — providing significant symptom relief.
However, since angioplasty and bypass directly open blockages, they remain the primary choice for acute and operable cases.
EECP is mostly used as an adjunct or alternative therapy when invasive options are not possible or safe.
Discover How EECP Can Help You
Safe, non-invasive, and effective therapy for heart patients. Available now at Oplus Heart Centre. Book an Appointment